Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial.
Clin Gastroenterol Hepatol
; 20(3): 525-534.e10, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-33887475
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Eosinophilic Esophagitis
Type of study:
Clinical_trials
Limits:
Humans
/
Newborn
Language:
En
Journal:
Clin Gastroenterol Hepatol
Journal subject:
GASTROENTEROLOGIA
Year:
2022
Document type:
Article
Country of publication:
United States